Stepping Into the Era of Combination Cancer Therapies, Part 2: Combining Targeted Therapies
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
Just before the holidays, the U.S. Food and Drug Administration (FDA) had good news for the ovarian cancer research...
Last week, more than 100 patients, survivors, family members, advocates, and researchers came together for a symposium at the...
In the coming months, we will share posts from advocates who participated in the AACR’s Scientist↔Survivor Program at the...